Why Tenet is projecting strong 2023 results

A week ahead of the release of its fourth-quarter earnings, Dallas-based Tenet Healthcare said it is expecting its adjusted EBITDA for the year ended Dec. 31 will be “above the high end” of its current guidance range. 

Advertisement

Those results were driven by, among other factors, strong surgical growth at its ASC business, United Surgical Partners International, Tenet said in a Feb. 1 news release. 

“Our team continues to deliver consistently strong results, driven by Tenet’s data-driven and disciplined operating model,” Tenet CEO Saum Sutaria, MD, said in the release. 

Tenet will release its fourth-quarter and full-year earning results Feb. 8. 

The health system’s adjusted EBITDA for 2022 was $3.47 billion. Tenet said in its Oct. 30 quarterly earnings report that it increased its adjusted EBITDA outlook for 2023 to be in the range of $3.37 billion to $3.47 billion. 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Financial Management

  • Baylor College of Medicine and Texas Children’s Hospital established an affiliation more than 70 years ago in the Texas Medical…

  • Fitch revised Ontario, Calif.-based Prime Healthcare Services’ outlook to positive and affirms its “B” rating.  The revised outlook reflects Fitch’s…

  • Brentwood, Tenn.-based Lifepoint Health, a health system owned by private equity firm Apollo Global Management, has largely grown over the…

Advertisement

Comments are closed.